Textbox: FDA Approval of GE Salmon

On November 19, 2015, the U.S. Food and Drug Administration (FDA) announced its long-awaited decision regarding AquaAdvantage Salmon, the first genetically engineered (GE) animal intended for food. The FDA has approved AquaBounty Technologies’ new animal drug application (NADA) for the Salmon, findi...

Full description

Bibliographic Details
Main Author: Negowetti, Nicole
Format: Text
Language:unknown
Published: ValpoScholar 2017
Subjects:
Atlantic salmon
Online Access:https://scholar.valpo.edu/law_fac_pubs/486
https://doi.org/10.1007/978-3-319-18002-1_15
id ftunivalparaiso:oai:scholar.valpo.edu:law_fac_pubs-1487
record_format openpolar
spelling ftunivalparaiso:oai:scholar.valpo.edu:law_fac_pubs-1487 2023-05-15T15:31:43+02:00 Textbox: FDA Approval of GE Salmon Negowetti, Nicole 2017-01-01T08:00:00Z https://scholar.valpo.edu/law_fac_pubs/486 https://doi.org/10.1007/978-3-319-18002-1_15 unknown ValpoScholar https://scholar.valpo.edu/law_fac_pubs/486 https://doi.org/10.1007/978-3-319-18002-1_15 Law Faculty Publications text 2017 ftunivalparaiso https://doi.org/10.1007/978-3-319-18002-1_15 2022-12-25T08:03:55Z On November 19, 2015, the U.S. Food and Drug Administration (FDA) announced its long-awaited decision regarding AquaAdvantage Salmon, the first genetically engineered (GE) animal intended for food. The FDA has approved AquaBounty Technologies’ new animal drug application (NADA) for the Salmon, finding that it meets the statutory requirements under the Federal Food, Drug, and Cosmetic Act (FDCA). In particular, the FDA determined that the Salmon’s rDNA construct is safe for the fish itself, the fish reaches market size more quickly than non-GE farm-raised Atlantic salmon (as AquaBounty claimed), and food from the fish is safe to eat and as nutritious as food from non-GE salmon. Text Atlantic salmon Valparaiso University: ValpoScholar 467 469 Cham
institution Open Polar
collection Valparaiso University: ValpoScholar
op_collection_id ftunivalparaiso
language unknown
description On November 19, 2015, the U.S. Food and Drug Administration (FDA) announced its long-awaited decision regarding AquaAdvantage Salmon, the first genetically engineered (GE) animal intended for food. The FDA has approved AquaBounty Technologies’ new animal drug application (NADA) for the Salmon, finding that it meets the statutory requirements under the Federal Food, Drug, and Cosmetic Act (FDCA). In particular, the FDA determined that the Salmon’s rDNA construct is safe for the fish itself, the fish reaches market size more quickly than non-GE farm-raised Atlantic salmon (as AquaBounty claimed), and food from the fish is safe to eat and as nutritious as food from non-GE salmon.
format Text
author Negowetti, Nicole
spellingShingle Negowetti, Nicole
Textbox: FDA Approval of GE Salmon
author_facet Negowetti, Nicole
author_sort Negowetti, Nicole
title Textbox: FDA Approval of GE Salmon
title_short Textbox: FDA Approval of GE Salmon
title_full Textbox: FDA Approval of GE Salmon
title_fullStr Textbox: FDA Approval of GE Salmon
title_full_unstemmed Textbox: FDA Approval of GE Salmon
title_sort textbox: fda approval of ge salmon
publisher ValpoScholar
publishDate 2017
url https://scholar.valpo.edu/law_fac_pubs/486
https://doi.org/10.1007/978-3-319-18002-1_15
genre Atlantic salmon
genre_facet Atlantic salmon
op_source Law Faculty Publications
op_relation https://scholar.valpo.edu/law_fac_pubs/486
https://doi.org/10.1007/978-3-319-18002-1_15
op_doi https://doi.org/10.1007/978-3-319-18002-1_15
container_start_page 467
op_container_end_page 469
op_publisher_place Cham
_version_ 1766362240100859904

Similar Items